Countdown to Next Report: Special Report with Game-Changing Potential Coming Your Way

Declares this radical biotechnology "is going to be flat out one of the biggest [tech revolutions] ever." And this $10 stock is at the center of all.  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Today's Top Stories and Partner Offers:

Nvidia CEO Says It Will Spark "the Next Revolution" Beyond AI - Ad Declares this radical biotechnology "is going to be flat out one of the biggest [tech revolutions] ever." And this $10 stock is at the center of all. Find out more. GameStop, AMC, Plug Power, Rumble, Tesla: Why These 5 Stocks Are Investors' Radars Today major U.S. stock indices closed higher, with the Dow Jones Industrial Average increasing by 0.3% to 39,558.11. Continue reading ➔ AI Medical Stock Landing Massive Contracts - Ad The company is tiny today, but big pharma is lining up to use its patent-protected technology. In short, it is the inventor of the world's first AI-designed drug to enter clinical trials. Currently, the stock trades for less than $10 today and is at the forefront of it all. Continue reading ➔ This Week: Home sales, Fed meeting minutes and consumer sentiment index A look at some of the key business events and economic indicators upcoming this week Continue reading ➔ Hope Hicks Testifies On Trump's Ex-Lawyer Michael Cohen's 'Mr. Fix It' Moniker: 'Only Because He Broke It First' The criminal trial against Donald Trump saw former Trump aide Hope Hicks take the stand Friday and discuss Michael Cohen and the "Access Hollywood" tape. Continue reading ➔ This under-the-radar company is primed for an incredible year! - Ad Every week we reveal diamonds in the rough, under-the-radar stocks so make sure you don't miss out! Text STOCKS to (833) 861-1388. Get today's top stock Demand Soars For Novo Nordisk's Weight-Loss Drug Wegovy Despite Supply Constraints And Eli Lilly Competition The Danish pharmaceutical company is now shipping more introductory doses of Wegovy to the U.S., as it grapples with supply constraints and competition from Eli Lilly. Continue reading ➔ Elon Musk Issues Stark Warning Amid Rising National Debt: '...The Dollar Will Be Worth Nothing' Elon Musk has voiced concerns about the future stability of the U.S. dollar, highlighting the escalating national debt as a potential catalyst for a looming economic crisis. Continue reading ➔ Must-See: Elon's New Invention is Absolutely Insane - Ad When you click here and see what Elon Musk's new invention does... And how it works... You will NOT believe it. You'll tell yourself this is just science fiction. But Elon just tested this in a real human... And the result was mind-blowing. See it here. Trump's Niece Says Ex-President Has Made It Clear He Wants To Be Authoritarian Upon Returning To Office: 'Once That Happens, He Will Not Be Stopped' Trump's niece suggests that her uncle has a split personality, emphasizing that people are not paying enough attention to his negative traits. Continue reading ➔ Stock market today: Asian shares advance after another round of Wall St records Asian shares were mostly higher on Thursday after U.S. stocks rallied to records on hopes that back in the right direction. Continue reading ➔ These 2 Simple Sentences Turn Every Friday Into Payday? - Ad Most people have never heard of Jim Fink. But, his trading strategy has a 97% accuracy at closing out winners -- for 8 years running. So how does he do it? Jim has agreed to reveal his personal options technique in a rare, one-on-one interview. Access this eye-opening interview here. Ukraine May Need To Negotiate With Russia To End War, Says Top Intel Officer: 'Both Sides Are Jockeying For The The Most Favorable Position' Ukraine may need to negotiate with Russia to end the war, as suggested by a senior intelligence official. Negotiations could begin in the second half of 2025. Continue reading ➔ Trump Faces Greater Threat Not From Michael Cohen, But From This Person, Says Scaramucci: 'This Wreckage Is Going To Come Back To Haunt Him Come November' The outcome of the hush-money case may not mean much for Trump, but he faces a graver threat, says Anthony Scaramucci. Continue reading ➔ Fraudsters target small businesses with scams. Here are some to watch out for NEW YORK (AP) — It's never fun to be scammed, but if you're a small business owner then falling for a scam can have long-lasting effects on a business, damaging client relationships and profit. Continue reading ➔ Last Week's Worst-Performing Stocks: Are These 15 Large-Cap Stocks In Your Portfolio? (April 28-May 4, 2024) 15 large-cap stocks had a rough week, with CVS, Starbucks, and DoorDash all taking major hits. Analysts have lowered price targets on many. Continue reading ➔ Hims & Hers Health CEO Under Fire After Expressing Support For Pro-Palestinian Student Protesters, Company Stock Plummets Hims & Hers Health Inc. (NYSE: HIMS) stock was hit significantly on Friday following its CEO's public support for pro-Palestinian protesters. Continue reading ➔ Ethereum's Bottom Against Bitcoin 'Still Likely A Few Months Away,' Predicts Crypto Analyst Prominent cryptocurrency analyst Benjamin Cowen predicted further bearish momentum for Ethereum (CRYPTO: ETH) to Bitcoi Continue reading ➔

Information, charts or examples contained in this email are for illustration and educational purposes only and not for individualized investment management. This message contains commercial elements, such as advertising as well as partner offers for which we may receive affiliate compensation. We only send these offers to those who have opted in to our newsletter. If you wish to no longer receive these offers click on the unsubscribe link at the bottom of this email. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained in this email or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault. 339-20 De Boers Dr., Toronto, ON M3J 0H1, 917.672.7040 © 2024 Musth | TechnicalTrading | All rights reserved. Unsubscribe